Western Financial Corp/Ca Alnylam Pharmaceuticals, Inc. Transaction History

Western Financial Corp/Ca

  • $176 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 26, 2023
BUY
$185.01 - $212.05 $120,996 - $138,680
654 Added 21.98%
3,630 $689 Million
Q1 2023

Apr 19, 2023
BUY
$182.66 - $235.53 $35,801 - $46,163
196 Added 7.05%
2,976 $596 Million
Q4 2022

Jan 19, 2023
BUY
$185.53 - $241.31 $515,773 - $670,841
2,780 New
2,780 $661 Million

Others Institutions Holding ALNY

# of Institutions
644
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $31.2B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Western Financial Corp/Ca Portfolio

Follow Western Financial Corp/Ca and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Western Financial Corp/Ca, based on Form 13F filings with the SEC.

News

Stay updated on Western Financial Corp/Ca with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email